Brain Signal Discovery Reveals New Autism Pathway and Potential Treatment Target
Scientists identify how nitric oxide triggers cellular changes in autism, offering hope for targeted therapies.
Summary
Researchers at Hebrew University discovered a molecular chain reaction that may contribute to autism spectrum disorders. The study found that nitric oxide, normally a helpful brain signaling molecule, can sometimes trigger problematic changes in neurons. When nitric oxide levels rise, it alters a protective protein called TSC2, which normally acts as a brake on cellular growth processes. Without this brake, the mTOR pathway becomes overactive, potentially disrupting normal brain cell function and communication. The encouraging finding is that blocking this specific step restored healthier cellular balance, suggesting a promising target for future autism treatments.
Detailed Summary
Scientists have identified a previously unknown molecular pathway that may contribute to autism spectrum disorders, offering new hope for targeted treatments. The research reveals how a common brain signaling molecule called nitric oxide can sometimes malfunction and trigger harmful changes in neurons.
Under normal conditions, nitric oxide helps fine-tune communication between brain cells. However, the Hebrew University study found that elevated nitric oxide levels can alter a crucial protective protein called TSC2 through a process called S-nitrosylation. TSC2 normally functions as a cellular brake, keeping the mTOR pathway under control. This pathway regulates essential processes like cell growth and protein production.
When nitric oxide modifies TSC2, it marks the protein for removal from cells. As TSC2 levels drop, its braking effect weakens, allowing mTOR signaling to surge beyond normal levels. This overactivity may interfere with how neurons function and communicate, potentially contributing to autism symptoms.
The most promising aspect of this discovery is that researchers successfully interrupted this chain reaction in laboratory experiments. When they blocked the specific step where nitric oxide modifies TSC2, cellular activity returned to healthier levels. This suggests the pathway could be a viable target for future autism therapies.
While this research provides valuable insights into autism biology, it represents early-stage laboratory findings. The work helps explain how various risk factors might lead to the brain changes observed in autism, filling an important gap in scientific understanding and potentially guiding development of more precise treatments.
Key Findings
- Nitric oxide can trigger harmful cellular changes in autism by modifying the TSC2 protein
- Loss of TSC2 protein removes cellular brakes, causing mTOR pathway overactivity
- Blocking nitric oxide modification of TSC2 restored normal cellular function
- This pathway may explain how autism risk factors lead to brain changes
Methodology
This is a news report summarizing peer-reviewed research published in Molecular Psychiatry, a leading Nature journal. The study from Hebrew University used systems-level protein analysis and laboratory experiments to investigate molecular mechanisms.
Study Limitations
The article appears incomplete, cutting off mid-sentence. These are early laboratory findings that require validation in clinical studies. The research doesn't yet translate to available treatments or prevention strategies.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.